Form S-1

Longeveron Files Registration Statement for Rights Offering

Retrieved on: 
Tuesday, June 27, 2023

Longeveron’s registration statement on Form S-1 covers a rights offering for up to $30,000,000 of shares of common stock.

Key Points: 
  • Longeveron’s registration statement on Form S-1 covers a rights offering for up to $30,000,000 of shares of common stock.
  • See our SEC filings here for more details about the potential rights offering as well as information on the company.
  • EDGAR Search Results (sec.gov)
    If you have any questions or need further information about this rights offering, please call Okapi Partners, Longeveron’s information agent for the rights offering, at (212) 297-0720 (bankers and brokers) or (844) 201-1170 (all others) or email at [email protected] .
  • The rights offering will be made only by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended.

Nabors Announces Filing of SPAC Registration Statement

Retrieved on: 
Thursday, June 22, 2023

HAMILTON, Bermuda, June 22, 2023 /PRNewswire/ -- Nabors Industries Ltd. ("Nabors" or the "Company") (NYSE: NBR), a leading provider of advanced technology for the global energy industry, announced today that Nabors Energy Transition Corp. II ("NETD"), a newly formed special purpose acquisition company and an affiliate of Nabors, has filed a registration statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") in connection with a proposed initial public offering of its units.

Key Points: 
  • HAMILTON, Bermuda, June 22, 2023 /PRNewswire/ -- Nabors Industries Ltd. ("Nabors" or the "Company") (NYSE: NBR), a leading provider of advanced technology for the global energy industry, announced today that Nabors Energy Transition Corp. II ("NETD"), a newly formed special purpose acquisition company and an affiliate of Nabors, has filed a registration statement on Form S-1 (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") in connection with a proposed initial public offering of its units.
  • There can be no assurance the public filing of a registration statement on Form S-1 will result in any transaction or other action by Nabors.
  • A registration statement, including a prospectus, which is preliminary and subject to completion, relating to these securities has been filed with the SEC but has not yet become effective.
  • These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

Applied UV Announces Pricing of $5,000,000 Underwritten Public Offering

Retrieved on: 
Friday, June 16, 2023

MOUNT VERNON, NY, June 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (Nasdaq: AUVI ) (“Applied UV” or the “Company”), a global leading provider of advanced food security and air and surface disinfection technology, announced the pricing of its underwritten public offering of 5.0 million shares of common stock (the "Common Stock") and pre-funded warrants at a public offering price of $1.00 per share (less $0.001 in exercise price per pre-funded warrant), for aggregate gross proceeds of approximately $5.0 million, prior to deducting underwriting discounts and other offering expenses.

Key Points: 
  • MOUNT VERNON, NY, June 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (Nasdaq: AUVI ) (“Applied UV” or the “Company”), a global leading provider of advanced food security and air and surface disinfection technology, announced the pricing of its underwritten public offering of 5.0 million shares of common stock (the "Common Stock") and pre-funded warrants at a public offering price of $1.00 per share (less $0.001 in exercise price per pre-funded warrant), for aggregate gross proceeds of approximately $5.0 million, prior to deducting underwriting discounts and other offering expenses.
  • The Company expects to use the net proceeds of this offering for general corporate purposes, including new investments.
  • Aegis Capital Corp. is acting as the sole book-running manager for the Offering.
  • The Offering was made pursuant to an effective registration statement on Form S-1 (No.

Bone Biologics Prices $5.0 Million Underwritten Public Offering

Retrieved on: 
Thursday, June 15, 2023

Bone Biologics Corporation (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced the pricing of an underwritten public offering of common stock.

Key Points: 
  • Bone Biologics Corporation (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced the pricing of an underwritten public offering of common stock.
  • Bone Biologics is selling 2,538,071 shares of its common stock in the offering.
  • The shares of common stock are being sold at a price to the public of $1.97 per share, for aggregate gross proceeds of approximately $5.0 million, before deducting underwriting discounts and offering expenses.
  • EF Hutton, division of Benchmark Investments, LLC is acting as the sole book-running manager for the offering.

SpringBig Holdings, Inc. Announces Pricing of $4.0 Million Public Offering

Retrieved on: 
Friday, May 26, 2023

The closing of the offering is expected to occur on or about May 31, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about May 31, 2023, subject to the satisfaction of customary closing conditions.
  • Roth Capital Partners is acting as sole placement agent for the offering.
  • The gross cash proceeds to the Company from the offering are expected to be approximately $3.0 million, before deducting the placement agent’s fees and other offering expenses payable by springbig.
  • “We are delighted to have strengthened our balance sheet with this public offering and are appreciative of the willingness of L1 Capital to support the future growth of springbig,” said Paul Sykes, CFO of springbig.

Biocept Announces Pricing of $5.0 Million Underwritten Public Offering

Retrieved on: 
Thursday, May 25, 2023

The gross proceeds to Biocept from this offering are expected to be approximately $5.0 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Biocept.

Key Points: 
  • The gross proceeds to Biocept from this offering are expected to be approximately $5.0 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Biocept.
  • The offering is expected to close on May 26, 2023, subject to customary closing conditions.
  • Biocept expects to use the net proceeds from the offering for the advancement of its FORESEE trial for CNSide, working capital and general corporate purposes.
  • Biocept has also granted the underwriters a 45-day option to purchase up to an additional 176,470 shares of common stock and accompanying warrants to purchase up to 352,940 shares of common stock, at the public offering price less discounts and commissions.

Harbor Custom Development, Inc. Announces Closing of $10 Million Public Offering

Retrieved on: 
Thursday, May 18, 2023

The warrants have an exercise price of $5.00 per share, are exercisable immediately upon issuance, and expire five years from the date of issuance.

Key Points: 
  • The warrants have an exercise price of $5.00 per share, are exercisable immediately upon issuance, and expire five years from the date of issuance.
  • H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from this offering were approximately $10 million before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The offering was made only by means of a prospectus which forms a part of the effective registration statement.

Assure Holdings Corp. Announces Closing Of $6 Million Underwritten Public Offering

Retrieved on: 
Tuesday, May 16, 2023

DENVER, May 16, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock (or prefunded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant).

Key Points: 
  • DENVER, May 16, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (NASDAQ: IONM) (“Assure Holdings” or the “Company”), a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock (or prefunded warrants in lieu thereof) at an offering price to the public of $1.20 per share (or $1.199 per pre-funded warrant).
  • Joseph Gunnar & Co., LLC acted as the sole book-running manager for the offering.
  • The gross proceeds to the Company from the offering are approximately $6 million, before deducting the underwriters’ fees and other offering expenses payable by Assure.
  • The offering was made only by means of a prospectus which is a part of the effective registration statement.

Harbor Custom Development, Inc. Announces Pricing of $10 Million Public Offering

Retrieved on: 
Tuesday, May 16, 2023

The closing of the offering is expected to occur on or about May 18, 2023, subject to the satisfaction of customary closing conditions.

Key Points: 
  • The closing of the offering is expected to occur on or about May 18, 2023, subject to the satisfaction of customary closing conditions.
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
  • The gross proceeds to the Company from this offering are expected to be approximately $10 million before deducting the placement agent’s fees and other offering expenses payable by the Company.
  • The offering is being made only by means of a prospectus which forms a part of the effective registration statement.

Strong Global Entertainment Announces Pricing of Initial Public Offering

Retrieved on: 
Tuesday, May 16, 2023

Charlotte, NC, May 15, 2023 (GLOBE NEWSWIRE) -- Strong Global Entertainment, Inc. (the “Company”) (NYSE American: SGE), today announced the pricing of its initial public offering of 1,000,000 shares of its Class A Common Voting Shares (the “Common Shares”) at a public offering price of $4.00 per share, for gross proceeds of $4 million, before deducting underwriting discounts and offering expenses.

Key Points: 
  • Charlotte, NC, May 15, 2023 (GLOBE NEWSWIRE) -- Strong Global Entertainment, Inc. (the “Company”) (NYSE American: SGE), today announced the pricing of its initial public offering of 1,000,000 shares of its Class A Common Voting Shares (the “Common Shares”) at a public offering price of $4.00 per share, for gross proceeds of $4 million, before deducting underwriting discounts and offering expenses.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 150,000 Common Shares to cover over-allotments at the initial public offering price, less the underwriting discount.
  • The net proceeds from the initial public offering are planned to be used for general corporate purposes, which may include (i) working capital, (ii) capital expenditures, (iii) operational purposes, and (iv) potential acquisitions of complementary businesses.
  • The final prospectus will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov .